Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4826
PUT
Blackstone Secured Lending
BXSL
$5.72B
| $2.82M | ﹤0.01% |
96,200
+49,700
| +107% | +$1.5M |
|
4827
Seacoast Banking Corp of Florida
SBCF
$3.4B
| $2.82M | ﹤0.01% |
105,722
+4,242
| +4% | +$112K |
|
4828
Washington Trust Bancorp
WASH
$748M
| $2.82M | ﹤0.01% |
87,414
+3,784
| +5% | +$116K |
|
4829
CALL
Acadia Healthcare
ACHC
$2.55B
| $2.82M | ﹤0.01% |
44,400
+20,600
| +87% | +$1.49M |
|
4830
iShares Micro-Cap ETF
IWC
$1.5B
| $2.82M | ﹤0.01% |
22,829
-21,447
| -48% | -$2.59M |
|
4831
CALL
Azenta
AZTA
$1.56B
| $2.81M | ﹤0.01% |
58,100
+18,900
| +48% | +$983K |
|
4832
PUT
Immunovant
IMVT
$9.16B
| $2.81M | ﹤0.01% |
98,700
+39,500
| +67% | +$1.16M |
|
4833
CALL
Rollins
ROL
$17.4B
| $2.81M | ﹤0.01% |
55,600
-20,100
| -27% | -$993K |
|
4834
Chegg
CHGG
$84.4M
| $2.81M | ﹤0.01% |
1,588,424
+284,676
| +22% | +$697K |
|
4835
CALL
Bio-Rad Laboratories Class A
BIO
$9.74B
| $2.81M | ﹤0.01% |
8,400
+100
| +1% | +$31.8K |
|
4836
PUT
Vicor
VICR
$9.57B
| $2.81M | ﹤0.01% |
66,700
-1,000
| -1% | -$37.2K |
|
4837
PUT
Ingersoll Rand
IR
$31.5B
| $2.81M | ﹤0.01% |
28,600
+24,100
| +536% | +$2.24M |
|
4838
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$267M
| $2.81M | ﹤0.01% |
44,343
+40,949
| +1,207% | +$2.47M |
|
4839
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF
MFEM
$155M
| $2.81M | ﹤0.01% |
132,195
+71,346
| +117% | +$1.44M |
|
4840
CALL
Bio-Techne
TECH
$11.3B
| $2.81M | ﹤0.01% |
35,100
-8,400
| -19% | -$631K |
|
4841
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.14B
| $2.8M | ﹤0.01% |
106,247
+64,103
| +152% | +$1.66M |
|
4842
NextNav
NN
$3.08B
| $2.8M | ﹤0.01% |
374,452
-189,939
| -34% | -$1.47M |
|
4843
PUT
Corcept Therapeutics
CORT
$12.9B
| $2.8M | ﹤0.01% |
60,600
-10,400
| -15% | -$370K |
|
|
DCH
4844
CALL
Dauch Corp
DCH
$1.57B
| $2.8M | ﹤0.01% |
452,800
+323,500
| +250% | +$2.11M |
|
4845
CALL
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$50.2M
| $2.8M | ﹤0.01% |
47,910
+7,990
| +20% | +$485K |
|
4846
Charles River Laboratories
CRL
$13.8B
| $2.8M | ﹤0.01% |
14,197
-14,665
| -51% | -$3.05M |
|
4847
PUT
Service Corp International
SCI
$11.3B
| $2.79M | ﹤0.01% |
35,400
+6,800
| +24% | +$517K |
|
4848
Mizuho Financial
MFG
$123B
| $2.79M | ﹤0.01% |
668,281
+43,401
| +7% | +$181K |
|
4849
Lloyds Banking Group
LYG
$85.5B
| $2.79M | ﹤0.01% |
894,396
+727,781
| +437% | +$2.18M |
|
4850
PGIM Active High Yield Bond ETF
PHYL
$1.41B
| $2.79M | ﹤0.01% |
+77,844
| New | +$2.73M |
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,614 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.